{"id":509,"date":"2025-12-12T17:37:26","date_gmt":"2025-12-12T17:37:26","guid":{"rendered":"https:\/\/avantsigna.com\/home\/"},"modified":"2026-03-10T17:21:18","modified_gmt":"2026-03-10T17:21:18","slug":"home","status":"publish","type":"page","link":"https:\/\/avantsigna.com\/es_es\/","title":{"rendered":"Legal business partners in the Life Sciences Field"},"content":{"rendered":"
\n
<\/h6>

be certain that your business agreements will protect your interests<\/h1><\/div>
Learn More About Our Strategies<\/span><\/path><\/svg><\/a><\/div><\/div><\/div>\n<\/div><\/div>\n\n\n\n
\n
<\/div>\n\n\n\n
\n
About<\/h6>

We’re dedicated to achieving commercial advantages for our clients and a safe contractual posititon. <\/h3><\/div>

With a passion for helping businesses suceed, we make sure that the final deal is the right next step for your business and we get it signed.<\/p><\/div><\/div><\/div>\n\n\n\n

\n
Read more<\/div><\/path><\/svg><\/span><\/a><\/div><\/div>\n<\/div><\/div>\n<\/div>\n<\/div>\n\n\n\n
\n
Services<\/h6>

What we do<\/h2><\/div><\/div><\/div><\/div>\n\n\n\n
<\/div><\/div>\n\n\n\n
\n
01<\/h6>

Negotiation and Legal review of Business Agreements<\/h4><\/div>

Our team will work closely with yours to define the business objectives of each deal and draft tailored contracts to achieve these while minimizing risks by including or negotiating provisions with the supplier or counterparty. The result of our work is an agreement ready to sign that allows your business to focus on the vendor’s performance and its value for the business, not the potential complications arising from the deal nor the time-consuming checks of contract wording, even when using AI.<\/p><\/div><\/div>\n\n\n\n

02<\/h6>

Compliance with pharmaceutical law <\/h4><\/div>

Our expert legal team will work closely with yours to define the business objectives of each deal and draft tailored contracts to achieve these while minimizing risks by including or negotiating provisions with the supplier or counterparty. The result of our work is an agreement ready to sign that allows your business to focus on the performance of the vendor and its value for the business.<\/p><\/div><\/div>\n\n\n\n

\n
Read more<\/div><\/path><\/svg><\/span><\/a><\/div><\/div>\n<\/div><\/div>\n<\/div>\n\n\n\n
\n
03<\/h6>

Competition Law Assessment<\/h4><\/div>



A basic assessment of your company’s position in each of the relevant markets where you are active is necessary in order to understand competition risks and therefore the possibilities of closing vertical agreements (such as manufacturing or distribution agreemetns) or certain agreements with potential competitors, that is, other pharma or Medical devices companies that have interesting assets, pipelines or distribution capabilities. <\/p><\/div><\/div>\n\n\n\n

04<\/h6>

Drafting SOPs and delivering corporate trainings<\/h4><\/div>

Jan has experience drafting Standard Operating Procedures for Pharmaceutical Companies concerning several matters and giving lectures or training programs to internal marketing or medical teams about pharmaceutical law. <\/p><\/div><\/div>\n\n\n\n

\n
Read more<\/div><\/path><\/svg><\/span><\/a><\/div><\/div>\n<\/div><\/div>\n<\/div>\n\n\n\n
\n
05<\/h6>

AI Governance & use of legal tech<\/h4><\/div>


We are up to date and can brief you on AI Governance regulations in Healthcare. We can make sure that your company complies with AI law and gets ready for the obligations due by July in Europe.

We can also help implementing technology into your organization, wether it AI-powered software for contract management or for any other purpose<\/p><\/div><\/div>\n\n\n\n

06<\/h6>

Trade Sanctions Compliance<\/h4><\/div>

We monitor global events and sanctions imposed by differnt countries, providing you with timely insights, recommendations, and support with the adaptation of your commercial strategy to tariffs and rapidly changing policies in respect of relations between countries where your company want to be active.<\/p><\/div><\/div>\n\n\n\n

\n
Read more<\/div><\/path><\/svg><\/span><\/a><\/div><\/div>\n<\/div><\/div>\n<\/div>\n<\/div><\/div>\n\n\n\n
\n
Hot Deals and relevant news<\/h6>

Insights & Analysis<\/h2><\/div><\/div><\/div><\/div>\n\n\n\n
<\/div><\/div>\n\n\n\n
\n
\"\"<\/div>
EU releases the new legal package – 10 March 2026<\/h6>
The final pharmaceutical package sets the framework for commercializing medicines in the EU <\/h5><\/div><\/div><\/div>\n\n\n\n
\"\"<\/div>
FDA approves Wegovy Pill – 4 Jan 26<\/h6>
Novo Nordisk’s shares up 10% last week after the news<\/h5><\/div><\/div><\/div>\n<\/div>\n\n\n\n
\n
\"\"<\/div>
International AI Safety Report 2026 is Published – 3 Feb 2026<\/h6>
This report analysis the capabilities and risks of general-purpose AI<\/h5><\/div><\/div><\/div>\n\n\n\n
\"\"<\/div>
Insilico Medicines trading as Public Company<\/h6>
Insilico Shares deliver good results during the first day as a Public Company<\/h5><\/div><\/div><\/div>\n<\/div>\n\n\n\n
\n
\"\"<\/div>
License deals surpass $250B – 3 February 2026<\/h6>
Licenses in Biopharma have totalled $250 Billion, J.P.Morgan says<\/h5><\/div><\/div><\/div>\n\n\n\n
\"\"<\/div>
AI for Healthcare<\/h6>
Anthropic and OpenAI both drop its models focused on healthcare, with different approaches<\/h5><\/div><\/div><\/div>\n<\/div>\n<\/div><\/div>\n\n\n\n
\n
Interested in our Services?<\/h6>

Explain your deals and projects and find out how we can help<\/h2><\/div><\/div><\/div><\/div>\n\n\n\n
\n
Contact us<\/div><\/path><\/svg><\/span><\/a><\/div><\/div>\n<\/div><\/div>\n<\/div><\/div>\n\n\n\n
\n
\n\t\t\t
\n\t\t\t\t\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t<\/path><\/svg>\n\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t<\/div>\n\t\t\t<\/div>\n\n\n\n
\n

\u2605\u2605\u2605\u2605\u2605
“The more I used Jan the more I realised that I needed him full-time.”\u200b<\/h4>

John Parsons<\/h6><\/div>

Executive Director at Organon<\/p><\/div><\/div><\/div>\n\n\n\n

\u2605\u2605\u2605\u2605\u2605
“I wouldn’t hesitate to recommend Jan and I would be happy for the opportunity to work with him again”\u200b\u200b<\/h4>

Matt Collins<\/h6><\/div>

Contracts Director at LabCorp<\/p><\/div><\/div><\/div>\n\n\n\n

\u2605\u2605\u2605\u2605\u2605
“Talking to Jan I quickly realised that he has a unique blend of legal and commercial skills and a business mindset.”<\/h4>

Dr. Chindu Kabir<\/h6><\/div>

CEO at PostOp<\/p><\/div><\/div><\/div>\n\n\n\n

\u2605\u2605\u2605\u2605\u2605
“I really enjoyed working with Jan, he is hard-working, smart and a great colleague, a team-player”\u200b<\/h4>

Siobhan Johnstone <\/h6><\/div>

Head of Legal at Gr\u00fcnenthal <\/p><\/div><\/div><\/div>\n<\/div>\n<\/div><\/div>\n\n\n\n

\n
\n

F.A.Q.<\/h2><\/div>

Find answers to commonly asked questions about our services <\/p><\/div><\/div>\n<\/div>\n\n\n\n